Korro Bio, Inc.

Contributing Author

Recent Articles by Korro Bio, Inc.

13 hours	Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference KRRO +7.77% GlobeNewswire
Nov-12	Korro Reports Third Quarter Financial Results, Provides Updates on KRRO-110 in Alpha-1 Antitrypsin Deficiency and Additional Pipeline Programs KRRO GlobeNewswire
Sep-02	Korro to Participate in Upcoming Investor and Scientific Conferences KRRO GlobeNewswire
Aug-12	Korro Reports Second Quarter 2025 Financial Results and Provides Business Updates KRRO GlobeNewswire
Jul-21	Korro Receives European Medicines Agency Orphan Drug Designation for KRRO-110 KRRO GlobeNewswire
May-14	Korro to Participate in Upcoming Investor Conferences KRRO GlobeNewswire
May-07	Korro Reports First Quarter 2025 Financial Results and Provides Business Updates KRRO GlobeNewswire